Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter VWF Antikörper (AA 1150-1250)

Dieses Kaninchen Monoklonal-Antikörper erkennt spezifisch VWF in IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7127055

Kurzübersicht für Rekombinanter VWF Antikörper (AA 1150-1250) (ABIN7127055)

Target

Alle VWF Antikörper anzeigen
VWF (Von Willebrand Factor (VWF))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 225
  • 44
  • 32
  • 12
  • 7
  • 6
  • 2
  • 1
Human

Wirt

  • 133
  • 130
  • 13
  • 7
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 158
  • 123
  • 2
Monoklonal

Konjugat

  • 133
  • 29
  • 18
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser VWF Antikörper ist unkonjugiert

Applikation

  • 188
  • 162
  • 80
  • 74
  • 63
  • 56
  • 49
  • 46
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 8
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 55
    • 22
    • 16
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1150-1250

    Spezifität

    Human von Willebrand factor (VWF or factor VIII-related antigen) is a 309 kDa multimeric plasma glycoprotein, important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Von Willebrand factor also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. Von Willebrand factor is synthesized by endothelial cells and is reported to be expressed in a number of tumors of vascular origin. IHC results aid in the classification of acute myeloid leukemia FAB type M7, angiosarcoma and epithelioid hemangioendothelioma.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 1150-1250) of human vWF protein (exact sequence is proprietary)

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HUVEC cells. Human tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    VWF (Von Willebrand Factor (VWF))

    Andere Bezeichnung

    VWF

    Hintergrund

    Coagulation Factor VIII, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD),von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)
    Cellular localisation: Cytoplasm.

    Molekulargewicht

    250kDa

    Gen-ID

    7450, 440848

    UniProt

    P04275
Sie sind hier:
Chat with us!